Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Specific immunotherapy, which involves the administration of allergic extracts to patients
with symptoms of allergic disorder, is the leading therapeutical tool of modern allergology.
According to the latest studies immunotherapy not only reduces symptoms' severity but also
may modify the course of allergic disease by reducing the risk of new sensitisations and
development of more advanced stages of the disease.It has been hypothesized basing on
clinical observation that perennial immunotherapy is more effective and safer in comparison
to preseasonal immunotherapy. The aim of the study was to compare the effect of perennial and
preseasonal immunotherapy on rhinoconjunctivitis symptoms and safety of both treatments.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Lodz Medical Universtity of Lodz